4sight Health August 31, 2023
David Burda

Don’t know what to think about the regulatory and competitive implications of Medicare negotiating the prices of 10 drugs with pharmaceutical companies? We had some thoughts on the new episode of the 4sight Health Roundup podcast.
  • David W. Johnson is CEO of 4sight Health.
  • Julie Vaughan...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Conferences / Podcast, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Trends
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article